Breaking News Instant updates and real-time market news.

CERN

Cerner

$62.49

-0.67 (-1.06%)

, SSYS

Stratasys

$22.29

-0.1 (-0.45%)

10:50
08/10/17
08/10
10:50
08/10/17
10:50

On The Fly: Top five analyst upgrades

Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Cerner (CERN) upgraded to Equal Weight from Underweight at Morgan Stanley. 2. Stratasys (SSYS) upgraded to Buy from Neutral at Citi with analyst Kenneth Wong saying the company's fiscal 2017 targets are achievable following its "strong" second quarter results. The analyst lowered his price target for the shares to $29 from $32. 3. Vantiv (VNTV) upgraded to Buy from Hold at Stifel with analyst John Davis saying the company's acquisition of WorldPay is "transformative" and "a strategic home run." 4. Autohome (ATHM) was upgraded to Buy from Hold at Benchmark and Deutsche Bank. 5. Cubic (CUB) upgraded to Overweight from Neutral at JPMorgan with analyst Mark Strouse citing valuation with the shares down 14% since the third quarter report on August 3. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

CERN

Cerner

$62.49

-0.67 (-1.06%)

SSYS

Stratasys

$22.29

-0.1 (-0.45%)

VNTV

Vantiv

$69.94

2.84 (4.23%)

ATHM

Autohome

$54.65

0.045 (0.08%)

CUB

Cubic

$42.25

2.05 (5.10%)

  • 10

    Aug

  • 18

    Sep

  • 19

    Sep

CERN Cerner
$62.49

-0.67 (-1.06%)

06/06/17
JPMS
06/06/17
NO CHANGE
Target $72
JPMS
Overweight
Cerner price target raised to $72 from $65 at JPMorgan
JPMorgan analyst Lisa Gill raised her price target for Cerner to $72 after the Department of Veteran Affairs announced its intent to use the company's Millennium platform as its Electronic Health Record system replacement. Assuming Cerner is able to secure a prime contractor role, the economics could be seven-to-14 times the size of the Department of Defense contract win, Gill tells investors in a research note. She sees the contract as creating a "longer term tail to growth" and keeps an Overweight rating on Cerner.
06/19/17
LEER
06/19/17
DOWNGRADE
Target $13
LEER
Market Perform
Allscripts downgraded to Market Perform from Outperform at Leerink
Leerink analyst David Larsen downgraded Allscripts (MDRX) to Market Perform and lowered his price target for the shares to $13 from $15. The analyst sees "significant attrition risk" to the company's Sunrise base as his channel checks indicate Cerner (CERN) and Epic are winning the vast majority of share. Further, the Republican healthcare bill "may put even more pressure on hospital budgets," Larsen tells investors in a research note.
08/10/17
MSCO
08/10/17
UPGRADE
MSCO
Equal Weight
Cerner upgraded to Equal Weight from Underweight at Morgan Stanley
08/10/17
08/10/17
UPGRADE
Target $62

Equal Weight
Cerner upgraded to Equal Weight share gains, IT Works traction at Morgan Stanley
As previously reported, Morgan Stanley upgraded Cerner to Equal Weight from Underweight and raised its price target to $62 from $59. Analyst Ricky Goldwasser raised his topline growth estimates to reflect share gains outside the current install base and wins for the new IT Works contract that increases his confidence in Q2 topline growth of 7%.
SSYS Stratasys
$22.29

-0.1 (-0.45%)

08/10/17
SBSH
08/10/17
UPGRADE
Target $29
SBSH
Buy
Stratasys upgraded to Buy from Neutral at Citi
Citi analyst Kenneth Wong upgraded Stratasys to Buy saying the company's FY17 targets are achievable following its "strong" Q2 results. The analyst adds sector sentiment is low and that Stratasys continues to trade at a discount to peers. He lowered his price target for the shares to $29 from $32.
07/24/17
LOOP
07/24/17
INITIATION
Target $24
LOOP
Hold
Stratasys initiated with a Hold at Loop Capital
Loop Capital analyst Ananda Baruah initiated Stratasys with a Hold and a $24 price target given strong year-to-date stock appreciation.
07/19/17
PIPR
07/19/17
NO CHANGE
PIPR
Underweight
Piper checks show 3D Systems had another challenging quarter
Piper Jaffray analyst Troy Jensen says feedback from 63 3D printing resellers indicates the demand uptick in Q1 has sustained in Q2 with system sales relatively in line with expectations and strong material sales helping profitability. Stratasys' (SSYS) results were "relatively balanced," but 3D Systems' (DDD) resellers expressed another challenging quarter for system demand, Jensen tells investors in a research note. The weakness at 3D Systems is directly correlated with the launch of HP's (HPQ) Jet Fusion printer, the analyst contends. He believes now is the time for investors to revisit the 3D printing space, preferring shares of Stratasys, Materialise (MTLS), Proto Labs (PRLB) and voxeljet (VJET). Jensen recommends avoiding shares of 3D Systems at current levels.
08/09/17
PIPR
08/09/17
NO CHANGE
Target $39
PIPR
Overweight
Stratasys guidance appears conservative, says Piper Jaffray
Piper Jaffray analyst Troy Jensen noted that Stratasys management reiterated their FY17 guidance, but said they see hitting the high end for revenues and operating margins, though he still believes the company's guidance is overly conservative given his expectation for accelerating product growth in the second half. The analyst, who adds that Stratasys' resellers that have indicated an uptick in system demand trends, raised his price target on the shares to $39 from $38 and keeps an Overweight rating on the stock.
VNTV Vantiv
$69.94

2.84 (4.23%)

08/10/17
STFL
08/10/17
UPGRADE
STFL
Buy
Vantiv upgraded to Buy from Hold at Stifel
08/10/17
STFL
08/10/17
UPGRADE
STFL
Buy
Vantiv upgraded on acquisition, risk/reward ratio at Stifel
As noted earlier, Stifel upgraded Vantiv to Buy from Hold. Analyst John Davis calls the company's acquisition of WorldPay "transformative" and "a strategic home run." He expects the stock's multiple to rise given the company's "longer term growth opportunities" and says that its risk/reward ratio is one of the most attractive of any stock he covers. Target to $85 from $63.
08/10/17
CHLM
08/10/17
NO CHANGE
Target $80
CHLM
Buy
Vantiv price target raised to $80 from $74 at Craig-Hallum
Craig-Hallum analyst Bradley Berning raised his price target for Vantiv to $80 from $74 after the company announced its plan to acquire Worldpay for a total enterprise value consideration of about $12B. The analyst reiterates a Buy rating on Vantiv's shares.
07/18/17
BARD
07/18/17
NO CHANGE
Target $72
BARD
Outperform
Vantiv shares viewed as good value at Baird
Baird analyst David Koning noted Vantiv responded to yesterday's negative report on pricing and still views the shares as a good value. He admitted pricing comparisons are difficult to assess as client size could be bigger and products could be better. The analyst has also stated in the past that pricing is a mild long-term industry risk, but noted it has been quite stable over the past 10 years. Koning reiterated his Outperform rating and $72 price target on Vantiv shares.
ATHM Autohome
$54.65

0.045 (0.08%)

08/10/17
BNCH
08/10/17
UPGRADE
Target $65
BNCH
Buy
Autohome upgraded to Buy from Hold at Benchmark
Benchmark analyst Fawne Jiang upgraded Autohome to Buy with a $65 price target following the company's Q2 results. Deutsche Bank this morning also upgraded the shares.
08/10/17
DBAB
08/10/17
UPGRADE
Target $65
DBAB
Buy
Autohome upgraded to Buy from Hold at Deutsche Bank
Deutsche Bank analyst Alvin Jiang upgraded Autohome to Buy and raised his price target for the shares to $65 from $36 following the better than expected Q2 results. Investment into new initiatives will likely peak in 2017, which will bring better margins on new business in 2018, Jiang tells investors in a research note.
06/02/17
UBSW
06/02/17
DOWNGRADE
UBSW
Sell
Autohome downgraded to Sell from Neutral at UBS
05/24/17
LYON
05/24/17
DOWNGRADE
LYON
Outperform
Autohome downgraded to Outperform from Buy at CLSA
CUB Cubic
$42.25

2.05 (5.10%)

08/10/17
JPMS
08/10/17
UPGRADE
Target $53
JPMS
Overweight
Cubic upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst Mark Strouse upgraded Cubic to Overweight citing valuation with the shares down 14% since the Q3 report on August 3. The analyst views the pullback as overdone and keeps a $53 price target for the stock.
03/24/17
ADAM
03/24/17
NO CHANGE
Target $60
ADAM
Buy
Cubic price target raised to $60 from $54 at Canaccord
Canaccord analyst Ken Herbert raised his price target on Cubic to $60 from $54 following meetings with management. Herbert believes Cubic is uniquely positioned with material tailwinds for its business and the company's business mix is favorable considering the funding priorities of the Trump administration. The company is optimistic about winning the NYC subway contract estimated at over $1B over ten years, added Herbert, who reiterated his Buy rating on Cubic shares.
12/22/16
DRXL
12/22/16
INITIATION
Target $58
DRXL
Buy
Cubic initiated with a Buy at Drexel Hamilton
Drexel Hamilton analyst Brian Rutternbur initiated Cubic with a Buy and a $58 price target.
10/14/16
ADAM
10/14/16
NO CHANGE
Target $50
ADAM
Buy
Cubic price target lowered to $50 from $54 at Canaccord
Canaccord analyst Ken Herbert lowered his price target on Cubic to $50 from $54 following the company's preannouncement that Q4 would be weaker than expected. The company also said it would provide conservative guidance for 2017. The company said the miss was due to customer timing issues but the analyst said it raises concern over top-line growth and margin expansion. Herbert, however, said a pullback would be a buying opportunity and he reiterated his Buy rating on Cubic shares.

TODAY'S FREE FLY STORIES

KSU

Kansas City Southern

$105.80

-0.07 (-0.07%)

17:45
08/18/17
08/18
17:45
08/18/17
17:45
Hot Stocks
Kansas City Southern director Henry Maier buys 3,000 shares »

Kansas City Southern…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

RXII

RXi Pharmaceuticals

$0.58

-0.02 (-3.36%)

17:27
08/18/17
08/18
17:27
08/18/17
17:27
Syndicate
Breaking Syndicate news story on RXi Pharmaceuticals »

RXi Pharmaceuticals files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

WIN

Windstream

$1.98

0.06 (3.13%)

17:27
08/18/17
08/18
17:27
08/18/17
17:27
Hot Stocks
Windstream CEO acquires 25,381 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVM

CEL-SCI

$2.44

-0.22 (-8.27%)

17:27
08/18/17
08/18
17:27
08/18/17
17:27
Syndicate
Breaking Syndicate news story on CEL-SCI »

CEL-SCI files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TRN

Trinity Industries

$28.20

-0.03 (-0.11%)

17:25
08/18/17
08/18
17:25
08/18/17
17:25
Hot Stocks
ValueAct raises stake inTrinity Industries to 11% from 9.8% »

As of this date, ValueAct…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LPTN

Lpath

17:11
08/18/17
08/18
17:11
08/18/17
17:11
Hot Stocks
Breaking Hot Stocks news story on Lpath »

Stonepine Capital reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PGR

Progressive

$48.63

0.12 (0.25%)

17:08
08/18/17
08/18
17:08
08/18/17
17:08
Hot Stocks
Progressive CFO sells 50,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TMO

Thermo Fisher

$172.57

-0.32 (-0.19%)

17:06
08/18/17
08/18
17:06
08/18/17
17:06
Hot Stocks
Thermo Fisher director sells 11,318 shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

SMBC

Southern Missouri Bancorp

$31.18

-0.05 (-0.16%)

17:06
08/18/17
08/18
17:06
08/18/17
17:06
Hot Stocks
Southern Missouri Bancorp and Southern Missouri Bancshares to merge »

Southern Missouri Bancorp…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IEP

Icahn Enterprises

$50.00

-0.2 (-0.40%)

16:58
08/18/17
08/18
16:58
08/18/17
16:58
Hot Stocks
Breaking Hot Stocks news story on Icahn Enterprises »

Icahn says ended advisory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IEP

Icahn Enterprises

$50.00

-0.2 (-0.40%)

16:57
08/18/17
08/18
16:57
08/18/17
16:57
Hot Stocks
Breaking Hot Stocks news story on Icahn Enterprises »

Icahn says ending…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IEP

Icahn Enterprises

$50.00

-0.2 (-0.40%)

16:57
08/18/17
08/18
16:57
08/18/17
16:57
Hot Stocks
Breaking Hot Stocks news story on Icahn Enterprises »

Icahn says never had…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IEP

Icahn Enterprises

$50.00

-0.2 (-0.40%)

16:56
08/18/17
08/18
16:56
08/18/17
16:56
Hot Stocks
Icahn no longer special advisor to President Trump on regulatory reform issues »

Carl Icahn, founder of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVTA

Invitae

$9.60

0.05 (0.52%)

16:55
08/18/17
08/18
16:55
08/18/17
16:55
Syndicate
Breaking Syndicate news story on Invitae »

Invitae files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVTA

Invitae

$9.60

0.05 (0.52%)

16:49
08/18/17
08/18
16:49
08/18/17
16:49
Syndicate
Breaking Syndicate news story on Invitae »

Invitae files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MU

Micron

$30.38

0.76 (2.57%)

16:48
08/18/17
08/18
16:48
08/18/17
16:48
Hot Stocks
Micron director sells 25,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Aug

  • 06

    Sep

INSY

Insys Therapeutics

$9.17

-0.11 (-1.19%)

16:42
08/18/17
08/18
16:42
08/18/17
16:42
Hot Stocks
Insys agrees to pay $4.45M to settle opioid marketing suit »

Illinois Attorney General…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AKTX

Akari Therapeutics

16:34
08/18/17
08/18
16:34
08/18/17
16:34
Syndicate
Breaking Syndicate news story on Akari Therapeutics »

Akari Therapeutics files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JMBA

Jamba

$9.11

-0.04 (-0.44%)

16:32
08/18/17
08/18
16:32
08/18/17
16:32
Hot Stocks
Jamba receives expected letter from Nasdaq »

Jamba, Inc. announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HIL

Hill International

$4.50

0.2 (4.65%)

16:31
08/18/17
08/18
16:31
08/18/17
16:31
Hot Stocks
Hill International receives NYSE notice regarding late Form 10-Q filing »

Hill International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TGT

Target

$55.65

-0.47 (-0.84%)

16:30
08/18/17
08/18
16:30
08/18/17
16:30
Periodicals
Target ends relationship with food startup Hampton Creek, Bloomberg says »

After an internal review,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:30
08/18/17
08/18
16:30
08/18/17
16:30
Options
Preliminary option volume of 23.2M today »

Preliminary option volume…

NBEV

New Age Beverages

$3.51

-0.49 (-12.25%)

16:29
08/18/17
08/18
16:29
08/18/17
16:29
Hot Stocks
New Age Beverages director sells nearly 42,000 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

ATW

Atwood Oceanics

$6.26

0.22 (3.64%)

, ESV

Ensco

$4.28

0.12 (2.88%)

16:24
08/18/17
08/18
16:24
08/18/17
16:24
Hot Stocks
Atwood Oceanics, Ensco file proxy materials in connection with pending merger »

Ensco (ESV) and Atwood…

ATW

Atwood Oceanics

$6.26

0.22 (3.64%)

ESV

Ensco

$4.28

0.12 (2.88%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NSRGY

Nestle

$83.76

-0.1 (-0.12%)

16:23
08/18/17
08/18
16:23
08/18/17
16:23
Periodicals
Nestle faces potential fraud suit over Poland Spring marketing, WSJ says »

Nestle is facing a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.